Polyethylene Glycol 3350

CHEMBL1201479 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Polyethylene glycol 3350 (PEG 3350) is an osmotic laxative that is not absorbed from the gastrointestinal tract and retains water in the intestinal lumen through osmosis, increasing stool frequency and softening stool consistency. It is used for the treatment of chronic constipation and as a bowel preparation agent, and has been studied in the management of Alzheimer's disease-related constipation.

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

Polyethylene glycol 3350 (PEG 3350) is an osmotic laxative that is not absorbed from the gastrointestinal tract and retains water in the intestinal lumen through osmosis, increasing stool frequency and softening stool consistency. It is used for the treatment of chronic constipation and as a bowel preparation agent, and has been studied in the management of Alzheimer's disease-related constipation.

Yes, Polyethylene Glycol 3350 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201479. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.